Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
AIDS (London, England)
|
December 3, 2010
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
Hiromi Imamichi, Gerald Degray, David M Asmuth, et al.
HIV Clinical Trials
|
August 22, 2014
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164
Philip M Grant, Lauren Komarow, Alejandro Sanchez, et al.
Journal of Virology
|
March 9, 2007
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection
J William Critchfield, Donna Lemongello, Digna H Walker, et al.
Antiviral Research
|
August 11, 2004
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection
David M Asmuth, Michael P Busch, Megan E Laycock, et al.
Journal of Medical Virology
|
October 11, 2024
Serum-derived bovine immunoglobulin treatment in COVID-19 is associated with faster resolution of symptoms: A randomized pilot clinical trial
Netanya S Utay, Roberto Güerri-Fernández, Shahin Gharakhanian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 4, 2012
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels
Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, et al.
The Journal of Infectious Diseases
|
June 29, 2002
Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis
W Lawrence Drew, Sunwen Chou, Richard C Miner, et al.
The Journal of Infectious Diseases
|
March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a
Jonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Antiviral Therapy
|
December 8, 2016
Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial
Juergen K Rockstroh, Frank Plonski, Meena Bansal, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
May 26, 2005
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes
David M Asmuth, Nan Wang, Ying Lu, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
AIDS (London, England)
|
December 3, 2010
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
Hiromi Imamichi, Gerald Degray, David M Asmuth, et al.
HIV Clinical Trials
|
August 22, 2014
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164
Philip M Grant, Lauren Komarow, Alejandro Sanchez, et al.
Journal of Virology
|
March 9, 2007
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection
J William Critchfield, Donna Lemongello, Digna H Walker, et al.
Antiviral Research
|
August 11, 2004
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection
David M Asmuth, Michael P Busch, Megan E Laycock, et al.
Journal of Medical Virology
|
October 11, 2024
Serum-derived bovine immunoglobulin treatment in COVID-19 is associated with faster resolution of symptoms: A randomized pilot clinical trial
Netanya S Utay, Roberto Güerri-Fernández, Shahin Gharakhanian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 4, 2012
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels
Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, et al.
The Journal of Infectious Diseases
|
June 29, 2002
Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis
W Lawrence Drew, Sunwen Chou, Richard C Miner, et al.
The Journal of Infectious Diseases
|
March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a
Jonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Antiviral Therapy
|
December 8, 2016
Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial
Juergen K Rockstroh, Frank Plonski, Meena Bansal, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
May 26, 2005
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes
David M Asmuth, Nan Wang, Ying Lu, et al.
Page
of 6